礼来公司股价上涨，因希望下一代药物将扩大减肥市场的领先地位 - 路透中文网

Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss market - Reuters

Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss market Reuters Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success WSJ Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause Yahoo Finance ADA: Lilly pulls back curtain on impressive triple-G efficacy in patients with obesity, diabetes Fierce Biotech Eli Lilly, Novo Both Share Good News on Weight-Loss Drugs. Only One Stock Is Rising. Barron's

这条新闻具备可验证事件线索，可继续观察是否形成 Yes/No 预测问题。

同主题新闻会帮助 Google 识别事件簇，也让用户继续进入可交易话题。